Inactive Instrument
Guided Therapeutics Inc Stock OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 17/06 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| 16/05 | Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 27.03M 23.63M 21.72M 20.24M 38.39M 2.57B 38.98M 261M 101M 1.27B 101M 99.28M 4.36B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 29.91M 26.14M 24.03M 22.4M 42.48M 2.85B 43.12M 288M 112M 1.4B 112M 110M 4.82B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.97% | +2.03% | +21.92% | +0.83% | 195B | ||
| +5.87% | +5.27% | -21.76% | +26.78% | 151B | ||
| +2.17% | +0.89% | -2.59% | -16.42% | 140B | ||
| +4.83% | +2.06% | -56.73% | -15.69% | 67.09B | ||
| +2.59% | +3.95% | +22.89% | +3.15% | 54.34B | ||
| +0.03% | +2.19% | -25.48% | -31.00% | 44.63B | ||
| +0.31% | +1.30% | +8.30% | +43.25% | 37.24B | ||
| -2.02% | -3.91% | +7.67% | +9.53% | 36.91B | ||
| +4.24% | +4.66% | -18.42% | -2.34% | 30.24B | ||
| Average | +2.22% | +2.74% | -7.13% | +2.01% | 83.99B | |
| Weighted average by Cap. | +2.78% | +3.44% | -4.03% | +2.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.12K 5.62K 5.24K 9.94K 666K 10.09K 67.51K 26.25K 328K 26.28K 25.71K 1.13M | 767K 671K 616K 574K 1.09M 73.03M 1.11M 7.4M 2.88M 35.9M 2.88M 2.82M 124M |
| Net income | -2.42M -2.11M -1.94M -1.81M -3.43M -230M -3.49M -23.31M -9.06M -113M -9.07M -8.88M -390M | -3.2M -2.79M -2.57M -2.39M -4.54M -304M -4.61M -30.82M -11.98M -150M -12M -11.74M -515M |
| Net Debt | 1.77M 1.55M 1.42M 1.33M 2.52M 169M 2.55M 17.08M 6.64M 82.89M 6.65M 6.5M 286M | 2.88M 2.51M 2.31M 2.15M 4.08M 274M 4.15M 27.74M 10.78M 135M 10.8M 10.56M 464M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















